We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EC icon
6776
CALL
Ecopetrol
EC
$36.3B
$977K ﹤0.01%
93,300
+32,300
+53% +$315K
MYGN icon
6777
CALL
Myriad Genetics
MYGN
$275M
$977K ﹤0.01%
67,300
+40,100
+147% +$747K
BCYC
6778
Bicycle Therapeutics
BCYC
$279M
$977K ﹤0.01%
32,990
-15,414
-32% -$414K
ICUI icon
6779
CALL
ICU Medical
ICUI
$4.58B
$976K ﹤0.01%
6,200
-3,900
-39% -$594K
MATV icon
6780
PUT
Mativ Holdings
MATV
$658M
$974K ﹤0.01%
46,600
+29,030
+165% +$629K
BIOX icon
6781
Bioceres Crop Solutions
BIOX
$26.7M
$974K ﹤0.01%
+80,930
New +$1.05M
PHO icon
6782
Invesco Water Resources ETF
PHO
$2.03B
$973K ﹤0.01%
+18,885
New +$952K
TWOU
6783
CALL
DELISTED
2U Inc
TWOU
$972K ﹤0.01%
5,170
-470
-8% -$93.2K
YELL
6784
DELISTED
Yellow Corporation Common Stock
YELL
$972K ﹤0.01%
387,439
+107,388
+38% +$382K
RFDA icon
6785
ALPS Dynamic US Dividend Advantage ETF
RFDA
$85.1M
$972K ﹤0.01%
+23,187
New +$976K
AGI icon
6786
Alamos Gold
AGI
$13.8B
$972K ﹤0.01%
96,138
-246,450
-72% -$2.17M
ASLN
6787
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$971K ﹤0.01%
67,463
+835
+1% +$16.1K
VOTE icon
6788
TCW Transform 500 ETF
VOTE
$1.13B
$971K ﹤0.01%
21,961
-21,090
-49% -$940K
PRN icon
6789
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$434M
$970K ﹤0.01%
11,233
+1,828
+19% +$160K
RXL icon
6790
ProShares Ultra Health Care
RXL
$91.8M
$970K ﹤0.01%
20,516
-19,014
-48% -$861K
EDC icon
6791
CALL
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$159M
$970K ﹤0.01%
+33,000
New +$899K
DSGR icon
6792
Distribution Solutions Group
DSGR
$1.61B
$970K ﹤0.01%
52,620
-62,322
-54% -$1.05M
STRO icon
6793
Sutro Biopharma
STRO
$360M
$970K ﹤0.01%
12,000
-18,209
-60% -$1.27M
ILCV icon
6794
iShares Morningstar Value ETF
ILCV
$1.35B
$969K ﹤0.01%
+15,332
New +$958K
CUZ icon
6795
Cousins Properties
CUZ
$4.78B
$969K ﹤0.01%
38,299
-734,556
-95% -$17.9M
FELE icon
6796
Franklin Electric
FELE
$4.53B
$968K ﹤0.01%
12,143
-31,865
-72% -$2.63M
DIVO icon
6797
CALL
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.89B
$968K ﹤0.01%
27,000
-7,700
-22% -$272K
FFWM
6798
DELISTED
First Foundation Inc
FFWM
$968K ﹤0.01%
67,550
+52,367
+345% +$811K
BALT icon
6799
Innovator Defined Wealth Shield ETF
BALT
$2.81B
$968K ﹤0.01%
+36,402
New +$956K
BINI
6800
DELISTED
Bollinger Innovations
BINI
0

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.